drugset / Trial / NCT03555071
A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate consistency, immunogenicity and safety of live attenuated varicella vaccines manufactured at commercialized scale in aged 1-3 years children.
Timeline
- Start
- 2014-04-07
- Primary completion
- 2017-05-20
- Completion
- 2017-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Live Attenuated Varicella Vaccine | Vaccine | 0.5 ml | Subcutaneous |